Roopjeet Kaur Bath, MBBS

Roopjeet Bath practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.

Roopjeet Bath's NPI, 1699901041, was assigned on May 29, 2009. Roopjeet Bath holds Connecticut license 055662.

Roopjeet Bath's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.

Roopjeet Bath's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Roopjeet Bath is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Roopjeet Bath practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Roopjeet Bath's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Roopjeet Bath's licenses on file in 2 states: Connecticut and Washington.

CMS data shows 153 Medicare services from Roopjeet Bath across 6 procedure codes in 2024, for 135 Medicare patients. Medicare paid $17,126 for them.

CMS counts 135 Medicare patients who saw Roopjeet Bath in 2024. The largest group is 65 to 74, with 63 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Roopjeet Bath's median patient age at 66, with 60% women.

In 2024, Roopjeet Bath wrote 508 Medicare Part D claims for 111 patients. 81% of them were for generic drugs. CMS names the drug for 424 of them, across 13 drugs with 11 or more claims each, at $159,703 in total drug cost. In 2023, CMS named 451 claims across 14 drugs.

Roopjeet Bath accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Roopjeet Bath, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Roopjeet Bath, published from 2015 to 2025. 2022 was the busiest year, with 2. Roopjeet Bath has published most often in Cureus. Roopjeet Bath's most frequent co-authors are Erica Becker, MD, John W. Birk, MD and Sheena Mago.

CMS Open Payments shows 12 general payments to Roopjeet Bath from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $249.